John Haydon has put a face on the power of social media and on the willingness of pharmaceutical companies to support patients to deal with the high cost of their […]
In the fast-moving world of biopharmaceuticals, the University of Delaware is preparing to demonstrate the importance of being NIIMBL. Launched at UD’s Delaware Biotechnology Institute last year, the National Institute […]
Reid Huber, executive vice president and chief scientific officer at Incyte, has a simple formula for how the company can keep ahead in a drug therapy environment that is moving […]
The pharmaceutical company Noramco, headquartered on the Wilmington riverfront, has signed a letter of intent with Teewinot Life Sciences to produce pharmaceutical-grade cannabinoids, the chemical compounds in cannabis flowers and […]
© 2023 Delaware Business Times
Flash Sale! Subscribe to Delaware Business Times and save 50%.
Limited time offer. New subscribers only.